Pulmonary perfusion disorders provoke atelectasis in order to minimize ventilation/perfusion mismatch. However, the underlying mechanisms remain unknown. Because intraalveolar CO 2 concentration ([CO 2 ] iA ) declines as a consequence of poor pulmonary perfusion we postulated the existence a novel alveolar CO 2 -sensing mechanism which adapts the ventilation to perfusion. Real-time fluorescence imaging of rat lungs revealed that low [CO 2 ] iA decreased cytosolic and increased mitochondrial Ca 2+ in alveolar epithelial cells (AEC), leading to reduction of surfactant secretion and alveolar ventilation. Mitochondrial inhibition by ruthenium red or rotenone blocked the hypocapnia-induced responses. In cultured Type 2 AEC hypocapnia decreased cytosolic Ca 2+ independently from pH and increased the NADH production, the mitochondrial transmembrane potential (ΔΨ), and subsequently the mitochondrial Ca 2+ uptake. All responses were completely blocked by the gene knockdown of the NADH producing Krebs cycle enzyme isocitrate dehydrogenase. Furthermore, ligature of the pulmonary artery of rabbits decreased alveolar ventilation, surfactant secretion, and lung compliance. Addition of 5% CO 2 to the inspiratory gas inhibited all responses. Accordingly, we provide evidence for a novel CO 2 -sensing mechanism of AEC regulated by the Krebs cycle activity in terms of a negative feedback loop adapting surfactant secretion and thus regional ventilation to pulmonary perfusion.
Introduction
The mismatch between alveolar ventilation and perfusion is a typical complication in critically ill patients and results in gas exchange failure and reduction of oxygen delivery to systemic circulation.
Ventilation disorders, as seen in pneumonia or atelectasis, are associated with regional alveolar hypoxia which evokes vasoconstriction of the pulmonary arteries. This well known response is termed hypoxic pulmonary vasoconstriction (HPV) and shifts as a compensatory mechanism blood from poorly to better ventilated lung segments, thereby reducing shunt fraction and optimizing gas exchange.
Perfusion disorders occurring during pulmonary artery embolism or systemic inflammation with intravascular coagulation cause a reduction of ventilation in poorly perfused lung segments. This response seems to be a mechanism that opposes HPV and was first described in 1934 by Moore, Humphreys and Cochrane. They showed that in dogs an occlusion of the left pulmonary artery leads to a ventilation reduction of the ipsilateral lung with simultaneously ventilation increase in the contralateral lung 1 . Occluding the right pulmonary artery induced a ventilation shift from right to left lung. Venrath et al . were able to demonstrate in 1952 the same ventilation shift in dogs using bronchospirometry 2 . Swenson and co-workers published similar results in 1961 after pulmonary artery occlusion in patients using a balloon catheter 3 .
Although the perfusion-mediated regulation of ventilation has been described by several authors, the underlying mechanism has never been elucidated.
Ventilation, at least in part, is regulated by surfactant which is secreted from Type 2 cells by exocytosis of lamellar bodies (LB). Secreted surfactant promotes alveolar opening by opposing the alveolar-collapsing tendency of air-liquid surface tension. LB exocytosis is triggered by an increase of cytosolic Ca 2+ concentration ([Ca 2+ ] cyt ) in Type 2 cells, which results from direct effects of agonists or cell stretch [4] [5] [6] .
We considered that alveolar CO 2 may play a crucial role in this scenario. Assuming that alveolar CO 2 concentration drops in non-perfused but still ventilated alveoli the alveolar CO 2 concentration could signal whether the alveolus is being perfused. We therefore hypothesized that, in case of perfusion disorder, the decline of alveolar CO 2 concentration initiates a reduction of ventilation by regulating LB exocytosis in order to normalize the ventilationperfusion ratio.
CO 2 measurement systems have been described for plants and questionably for the brain stem 7, 8 . However, a CO 2 -sensing mechanism of alveolar epithelial cells in order to regulate the LB exocytosis and thus ventilation to changes in perfusion by a Ca
2+
-signal transduction pathway is still unknown.
In this context, the mitochondria require consideration. Mitochondria regulate [Ca 2+ ] cyt by sequestering Ca 2+ and releasing it to the cytosol [9] [10] [11] [12] [13] [14] . The mitochondrial accumulation of Ca 2+ is facilitated by the Ca 2+ uniporter which is located in the inner mitochondrial membrane 13 . Ca 2+ is stored inside the mitochondrial matrix in the form of osmotically inactive precipitates or is released back to the cytosol through the Ca 2+ /Na + or Ca 2+ /H + exchanger, which are also located on the inner membrane of the mitochondria 13 . The driving force for mitochondrial Ca 2+ uptake is the negative transmembrane potential gradient (ΔΨ) across the mitochondrial inner membrane 14 . The membrane potential is component of the proton-motive gradient and 4 is set up through proton extrusion by the respiratory chain. Regulation of the respiratory chain activity and thus ΔΨ is complex. However, there are some indications that the rate of respiration can be stimulated by NADH. This respiratory chain substrate is produced in the Krebs cycle by the enzymes isocytrate dehydrogenase and α-ketoglutarate dehydrogenase [15] [16] [17] together with CO 2 .
It is a common effect that an accumulation of the product may inhibit whereas a rapid clearance of the product may accelerate its enzymatic reaction rate. We therefore hypothesize that a pulmonary perfusion failure induces a decrease of [ 18 . However, the role of the Krebs cycle in CO 2 -sensing and surfactant secretion has not been described so far.
Using fluorescence microscopy of the lung that enables in situ live imaging of intact alveoli we could describe for the first time that alveolar epithelial cells response to changes of [CO 2 ] iA with a cytosolic Ca 2+ -signaling. In case of alveolar hypocapnia, as seen during pulmonary perfusion failure, Ca 2+ is shifted from the cytosol to the mitochondria regulated by an increase of the Krebs cycle activity. In turn, surfactant secretion and alveolar ventilation is reduced in order to minimize ventilation/perfusion mismatch. Furthermore, using in vivo imaging of lung surface and a pulmonary artery ligature model we could demonstrate that CO 2 admixed to the inspiratory gas inhibits the reduction of ventilation in non-perfused lung areas. ] cyt in alveolar epithelial cells by 45±3 nM (mean±SE, p<0.05). This increase was also reversible after lowering the inspiratory CO 2 fraction and the pCO 2 to normocapnic values (figure 1A-C). CO 2 sensing is mitochondrial triggered in situ. To determine the role of mitochondria in the CO 2 -mediated calcium signaling we microinjected into the alveolus ruthenium red, an inhibitor of the mitochondrial Ca 2+ uniporter, or rotenone, an inhibitor of the complex I of the respiratory chain. Pretreatment with ruthenium red inhibited the hypocapnia-induced decrease of [Ca 2+ ] cyt by about 50%. Rotenone blocked the hypocapnia-induced calcium decrease completely ( figure 1D ). Under normocapnic conditions neither ruthenium red nor rotenone did affect fura 2 ratio.
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Results
CO
Furthermore, we microinjected into the alveolus rhod 2, a fluorescent dye for mitochondrial Ca 2+ measurement, in combination with MTG for mitochondrial co-localisation (figure 2A). Hypocapnia induced an increase of rhod 2 fluorescence intensity equivalent for a rise of [Ca 2+ ] mito (figure 2B). Taken together, these results indicate that the hypocapnia-induced decrease of [Ca 2+ ] cyt was evoked by a calcium shift from the cytosol to the mitochondria mediated by the mitochondrial Ca 2+ uniporter and complex I.
Hypocapnia-dependent regulation of [Ca
2+
] cyt is pH-independent in vitro. In A549 cells the [Ca 2+ ] cyt responses to hypo-or hypercapnia were equivalent to those in the isolated lung ( figure 3A,B ] cyt . Furthermore, in unbuffered cells hypocapnia did not alter the cytosolic pH ( figure 3D ). We therefore conclude that the hypocapnia-induced [Ca 2+ ] cyt responses were pH independent.
Hypocapnia-induced cytosolic Ca 2+ shift is mitochondrial ΔΨ-mediated in vitro. Suspecting that hypocapnia induces a Ca 2+ shift from cytosol into mitochondria through an alteration of the mitochondrial membrane potential we loaded A549 cells with TMRM. Induction of hypocapnia at constant pH of 7.4 led to an increase of the ratio between the mitochondrial and cytosolic TMRM fluorescence intensity equivalent for increase of the mitochondrial ΔΨ ( figure 4A,B) . This response was blocked by rotenone ( figure 4C,D) . Since rotenone also inhibited the hypocapnia-induced decrease of [Ca 2+ ] cyt (figure 1D), we conclude that hypocapnia induces a Ca 2+ shift from cytosol into the mitochondrium through an increase of the mitochondrial membrane potential.
Hypocapnia-induced increase of the mitochondrial ΔΨ and thus decrease of [Ca
2+
] cyt is NADH-mediated in vitro. The Krebs cycle enzyme isocytrate dehydogenase (IDH) catalyzes 6 oxidative decarboxylation of isocitrate to α-ketoglutarate and requires NAD + , producing NADH. In turn, NADH is utilised in the respiratory chain which is necessary to sustain the mitochondrial membrane potential. To elucidate whether hypocapnia induces an acceleration of the NADH production which in turn increases ΔΨ and subsequently provokes a Ca 2+ shift from the cytosol to the mitochondria we downregulated the NADH producing IDH3G ( figure  4E ). The decrease of [Ca 2+ ] cyt and the increase of [Ca 2+ ] mito or ΔΨ following hypocapnia at constant pH of 7.4 was detectible in native and scrambled siRNA-treated A549 cells ( figure  4F-H,A,B) . However, all responses were completely absent in IDH3G downregulated cells ( figure 4F-H,A,B) . Additionally, in native cells hypocapnia increases the NADHconcentration in comparison to normocapnia measured by the biochemical NADH assay ( figure 4I ). This increase was elevated after inhibition of the NADH consuming complex 1 with rotenone ( figure 4I ). Furthermore, in control and scrambled siRNA-treated cells NADH autofluorescence increased following rotenone, which blocks the NADH consuming mitochondrial complex 1 ( figure 4J,K) . This increase was elevated upon induction of hypocapnia ( figure 4J,K) . In contrast, NADH fluorescence stayed stable following IDH3G gene knockdown (figure 4J,K). Taken together we conclude that under hypocapnic conditions Krebs cycle activity, NADH production, and thus ΔΨ increase and subsequently [Ca 2+ ] cyt decreses independently from pH. ] cyt were in direct dependency of intraalveolar CO 2 concentration. To elucidate whether the calcium shift from the cytosol to the mitochondria was responsible for the reduction of surfactant secretion during hypocapnia we first tested if surfactant secretion was promoted by calcium. Therefore, we intraalveolarly infused the intracellular Ca 2+ chelator BAPTA-AM and repeated the measurement of LTG fluorescence intensity under hypercapnic conditions. We could show that the hypercapniainduced acceleration of surfactant secretion was blocked and the LTG fluorescence intensity values were similar to those under normocapnic conditions ( figure 5C ). Secondly, we pretreated the alveolar epithelial cells with the mitochondrial inhibitor rotenone. This procedure blocked the hypocapnia-induced reduction of surfactant secretion ( figure 5C ). Furthermore, the rate of surfactant secretion under these conditions was similar to that under control conditions ( figure 5C ).
Hypocapnia reduces alveolar ventilation in situ.
To elucidate the effect of hypocapniainduced reduction of the surfactant secretion on the alveolar ventilation we performed bright field microscopy of a specific lung area at baseline and two hours of exposition with normcapnia (40 mmHg pCO 2 ) or hypocapnia (<10 mmHg pCO 2 ). Hypocapnia reduced the projected alveolar area by 21% compared to their normocapnia state. In contrast, in rotenonepretreated alveoli hypocapnia had no effect on the projected alveolar area (figure 5D and E).
Ligature of pulmonary artery reduces surfactant protein D-secretion and alveolar surface in White New Zealand Rabbits in vivo. Intravital microscopy of the lung surface of volume-controlled ventilated rabbits revealed that following pulmonary artery ligation for 2 hours the projected alveolar surface area decreased by about 30% . In contrast, inspiratory CO 2 admixture inhibited this decrease of the projected alveolar surface area ( figure 6A and B). In accordance with this observations surfactant protein D concentration in the BAL 7 decreased in lungs with ligated pulmonary arteries. This response was inhibited by 5% CO 2 ventilation (figure 6C and D).
Ligature of pulmonary artery reduces the compliance und increase the inspiratory pressure and and the resistance and decreases the compliance in White New Zealand Rabbits in vivo. Ligation of pulmonal artery with consecutive intraalveolar hypocapnia induced an increase of the inspiratory pressure and the resistance and a decrease of the compliance vs. control in vivo (figure 6E-G). In contrast, all responses were inhibited by the inspiratory CO 2 admixture of 5% (figure 6E-G).
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We provide evidence that in isolated perfused rat lungs AEC sense changes in alveolar CO 2 concentration. When alveolar CO 2 decreases, as seen in non-perfused but ventilated alveoli, AEC respond with a mitochondrially triggered reduction of [Ca 2+ ] cyt and thus reductions in both LB exocytosis and alveolar ventilation (figure 7). ] mito . To keep this error small we co-localized the rhod 2 fluorescence with the specific dye MTG. Furthermore, Ichimura and coworkers were able to demonstrate using a similar experimental setup that cell permeabilization revealed a quick release of the mainly cytosolic-localized fura 2 whereas the rhod 2 fluorescence stayed constant indicating that rhod 2 was mainly in the cytosol [21] [22] [23] [24] . In our case, hypocapnia induced a contrary change of [Ca 2+ ] in the cytosol or in the mitochondria. Since we cannot completely exclude cytosolic localization of rhod 2 our determined [Ca 2+ ] mito increase might therefore be underestimated. Additionally, we could show that the [Ca 2+ ] cyt response was inhibited by the blockade of the mitochondrial Ca 2+ uniporter with ruthenium red or the complex 1 with rotenone indicating a Ca 2+ shift from the cytosol into mitochondria. The inhibitory effect of ruthenium red was less effective than of rotenone, which can be explained 9 by their different cell permeability characteristics. Summarizing these findings we suggest that hypocapnia induced a Ca 2+ shift from the cytosol to the mitochondria. ] cyto following hypocapnia was mainly due to an inhibition of mitochondrial Ca 2+ uptake. Furthermore, the hypocapniainduced ER uptake of Ca 2+ could be ruled out because fura 2ff ratio did not change after lowering CO 2 (data not shown).
The inhibition of the CO 2 -induced Ca 2+ shift by rotenone further suggests that the driving force for the mitochondrial Ca 2+ uptake was an increase of the respiratory chain activity and hence transmembrane potential. This hypothesis was confirmed by the finding that the fluorescence of TMRM, which accumulates in mitochondria in a potential-dependent manner, was enhanced in A549 cells under hypocapnic conditions compared to normocapnic conditions 25, 26 . Addition of rotenone revealed a quick decrease of the TMRM fluorescence indicating that the respiratory chain activity is the important determinant of mitochondrial transmembrane potential. Further, hypocapnia induced an increase of the respiratory chain substrate NADH and the knockdown of isocitrate dehydrogenase, the NADH-producing Krebs cycle enzyme, inhibited the decrease of [Ca 2+ ] cyto under low CO 2 levels. The dependency of the respiratory chain activity from NADH has been demonstrated by Kuznetsov et al. 27 . Hence, in hypocapnia, NADH production and thus transmembrane potential, the driving force for the mitochondrial Ca 2+ uptake, is increased. We therefore suggest that CO 2 , a byproduct of the Krebs cycle, inhibits Krebs cycle activity in a negative feedback loop. Under hypocapnic conditions, this inhibitory effect of CO 2 on the Krebs cycle activity is reduced which subsequently increases NADH production and in turn the mitochondrial transmembrane potential. ] cyt induced by ionophores, cell stretch, or by secretagogues evoked surfactant secretion 5, 6 . However, the role of CO 2 on Ca
2+
-mediated LB secretion has so far not been elucidated. It has been reported that in lipopolysaccharide (LPS) treated Type 2 cells co-cultured with alveolar macrophages surfactant secretion did not change under hypercapnic conditions. Since surfactant responses to CO 2 were not measured in the absence of LPS it is not clear whether CO 2 was ineffective or the LPS inhibited a hypothetic CO 2 -mediated alteration in surfactant secretion 28 . Shepard and colleagues measured the volumetric density of LB in response to CO 2 in isolated and ventilated dog lungs 29 . The authors demonstrated that the LB density decreased at low CO 2 tension. However, the responsible cellular processes in terms of LB synthesis, secretion and/or reabsorption were not determined. Other potential aspects are that CO 2 might influence alveolar ventilation and that ventilation stimulates surfactant secretion 30 . Therefore, it is not clear whether the LB density responses observed were due to CO 2 or ventilation.
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During hypocapnia rotenone blocked not only the Ca 2+ shift from the cytosol to the mitochondria but also the inhibition of LB secretion. We therefore conclude that mitochondria regulate LB secretion by modifying [Ca 2+ ] cyt in a CO 2 -dependent fashion because cytosolic Ca 2+ chelation abolished LB secretion. Since rotenone had no effect on [Ca 2+ ] cyt or on LB secretion under normocapnic conditions (data not shown) we rule out direct interference of rotenone with the LB secretion process. It is known that rotenone inhibits the mitochondrial membrane potential and thus ATP production. ATP as a paracrine mediator induces surfactant secretion by ligating purinergic receptors 31 . In our experiments this mechanism, however, does not play a relevant role because LB secretion was enhanced and not inhibited following rotenone. ATP is also required for the endoplasmic Ca 2+ uptake evoked by Ca ] cyt did not change after rotenone.
Similar to LB secretion, the mean projected alveolar area decreased during hypocapnia and was also blocked by rotenone. Since surfactant reduces alveolar surface tension, it is likely that at constant alveolar pressure, as given in our experiments, the hypocapnia-induced reduction of the alveolar projected area was directly caused by the decrease of LB secretion. Tsang et al. showed in piglets that an acute pulmonary thrombembolism causes a compensatory ventilation shift out of non-perfused lung regions which is initiated by a hypocapnia-induced bronchoconstriction 19 . We assume that in our model bronchoconstriction is not of significant relevance because rotenone, which was administered directly into to alveolus by bypassing the regarding bronchioli, inhibited the hypocapnia-induced reduction of the projected alveolar area. It is important to consider that the buffer in which rotenone is dissolved interacts with the alveolar lining fluid. Thus, alveoli from the comparison groups were also treated with the vehicle. However, the potential buffer-induced dilution of surfactant might counter the inhibitory effect of rotenone. We point out that our interpretations are limited to a two-dimensional analysis of a three-dimensional alveolar geometry. Nevertheless, assuming a spherical shape of alveoli changes of the projected area would be signify even higher changes in alveolar volume. Therefore, the measurement of the projected alveolar area might underrepresent the alveolar ventilation. Taken together, our findings provide the first evidence that mitochondria regulate LB secretion and thus alveolar ventilation in a CO 2 -dependent manner.
To test whether the hypocapnia-induced reduction of LB secretion and as a consequence alveolar ventilation is a relevant mechanism in alveolar perfusion failure in order to minimize ventilation/perfusion mismatch, we carried out in vivo experiments with intravital lung microscopy and pulmonary artery ligature. In accordance with the in situ findings the occlusion of the pulmonary artery resulted in a decrease of the projected alveolar area indicating a reduction of ventilation in the non-perfused lung area. This finding confirms reports by several authors. Bruns and Sauerbruch were probably the first who in 1911 described that the ligature of a pulmonary artery branch in dogs resulted in a collapse of the corresponding pulmonary lobe 32 . In 2009 Tsang et al. reported that alteration of regional CO 2 tension correlates with the changes of regional ventilation 19 . As described above, the authors considered that a hypocapnia-induced bronchoconstriction was responsible for the ventilation reduction. We cannot exclude this mechanism in our experiments. However, we found that the decrease in alveolar ventilation following pulmonary artery ligature was accompanied by a reduction of the surfactant protein concentration in the BAL and that these responses were inhibited by adding CO 2 into the inspired gas. Since surfactant reduces alveolar surface tension we conclude that this mechanism plays at least a partial role in adapting ventilation to changes in perfusion.
In summary, we identify a novel CO 2 -sensing mechanism of AEC in which mitochondria play a key role. The functional consequence is a Ca 2+ -mediated regulation of LB secretion. We conclude that this mechanism regulates the reduction of ventilation in lung areas with perfusion failure in order to reduce ventilation/perfusion mismatch and thus optimize gas exchange. , and 20 mmol/l HEPES at pH 7.4) containing 4% dextran (70 kDa) and 1% FBS at pH 7.4 and osmolarity of 295 mosm. All esterified fluorescent probes were prepared as stock solutions in dimethylsulfoxide (DMSO).
In situ experiments
Lung preparation. Using the previously reported method, lungs were isolated from SpragueDawley rats (anesthetized with 1.2 Vol% isoflurane and intraperitoneal injection of 100 mg/kg ketamine and 20 mg/kg xylazinum (rompun™)), and perfused with autologous blood (14ml/min) at 37°C 33, 34 . Lungs were constantly inflated through an airway cannula with an airway pressure of 5 cmH 2 O with a normocapnic gas mixture of 30% O 2 , 5% CO 2 , and 65% N 2 under baseline conditions. Pulmonary artery and left atrial (P LA ) pressures were held at 10 and 2 cmH 2 O, respectively. Alveolar micropuncture. We gave intraalveolar injections by alveolar micropuncture according to previously reported methods 4, 34, 35 (see supplementary for details).
Hypocapnia/hypercapnia induction. Switching the inflation gas to a hypocapnic (30% O 2 , 0% CO 2 and, 70% N 2 ) or hypercapnic (30% O 2 , 10% CO 2 and, 60% N 2 ) mixture altered the pCO 2 of the venous blood to hypocapnic values from 36.8±6.5 to 6.6±2.3 mmHg or to 79.6±3.6 mmHg, respectively. Blood pO 2 was constant throughout (215±34 mmHg). To prevent CO 2 -diffusion to the ambient air across the exposed lung surface, we covered the lungs with gas-tight plastic.
Real-time lung imaging. Using an epifluorescence microscope (Axiotech, Zeiss, Göttingen, Germany) fluorophores were excited using appropriate interference filters and filter sets (Semrock, Rochester, USA) (see supplementary methods for details). ] mito we microinjected rhod 2-AM into an alveolus for 15min followed by a Ringer´s flush (see supplementary methods for details).
Alveolar Type II cell exocytosis of surfactant. To determine surfactant secretion in situ, we imaged single alveolar cells from isolated blood-perfused rat lung through the loss of cell fluorescence of intraalveolar microinjected LysoTracker Green (LTG) 35 .
Measurement of alveolar projected area.
To measure the influence of altered surfactant secretion through hypocapnia ([CO 2 ] iA <10mmHg), we took light microscopy pictures of the lung surface with 20x amplification and measured the size of the projected alveolar area by using the software Metamorph (Molecular Device; Downington, PA, USA). , and 20 mmol/l HEPES at pH 7.4) was microinjected and surfactant secretion, and alveolar projected area was determined under normocapnic and hypocapnic conditions.
In vitro experiments
Cell culture. Human lung carcinoma A549 cells with type 2 cell characteristics were grown in F-12K Medium (ATCC, Mahassa, VA, USA). This cell type has been widely used as a model to study the response of AEC in several conditions 39, 40 (see supplementary methods for details). Cytosolic pH measurement. Cells were loaded with the acetoxymethyl esters of BCECF (5 mM) 41 . Cytosolic pH was measured after induction of hypocapnia (<10 mmHg pCO 2 ) (see supplementary methods for details).
Mitochondrial membrane potential measurement. For mitochondrial membrane potential assessment, A549 cells were loaded with tetramethylrhodamine methyl ester (TMRM). This indicator dye is a lipophilic cation accumulated by mitochondria in proportion to the electrical potential across their inner membrane (Δψ) 42 . The wavelength for excitation was 560 nm while monitoring the emission at 590 nm. Addition of the mitochondrial depolarizer FCCP (50 nM) resulted in a rapid loss of the mitochondrial TMRM fluorescence.
Mitochondrial NADH production. NADH concentration was quantified by measuring its autofluorescence intensity. A549 were excitated with 360 nm while monitoring the emission at 510 nm. For proofing the mitochondrial production of NADH, its autofluorescence was colocalized with the mitochondria specific marker MTG. 
Reverse transcriptase polymerase chain reaction (RT-PCR). (see supplementary methods for details).
In-vivo experiments
Lung preparations. White male New Zealand rabbits were anesthetized by intravenous application of midazolam (0.1 mg/kg), fentanyl (5 μg/kg) and pancuronium bromide (0.3 mg/kg bw). The surgical preparation and experimental setup have previously been described in detail 43, 44 (see supplementary methods for details).
Intravital microscopy. Subpleural alveoli were sequentially visualized under a fluorescence microscope (Zeiss, Axiotech, Germany) during prolonged inspiration periods of 10 seconds. For video recordings a CCD camera (Photometrics Coolsnap HQ 2 , USA) and Metamorph software (Molecular Device; Downington, PA, USA) were used.
Measurement of alveolar projected area.
To measure the influence of altered surfactant secretion through hypocapnia we took light microscopy pictures of the lung surface with 20x amplification and measured the size of the projected alveolar area by using the software Metamorph (Molecular Device; Downington, PA, USA).
Experimental protocol. The rabbits were randomized into three groups: 1. control without pulmonal artery ligature (control-group), 2. pulmonal artery ligature (PA-ligature group), 3. pulmonal artery ligature with inspiratory application of CO 2 (therapy-group). Compliance, resistance and inspiratory pressure were measured by the respirator (Zeus ® , Dräger, Lübeck, Germany) and changes in projected alveolar area were visualized by light microscopy at baseline and after 120 minutes. At the end of videomicroscopy the animals were sacrificed and the lungs were lavaged for the measurement of the surfactant protein A-fraction by westernblotting.
Western blot. (see supplementary methods for details).
Statistics
All data are represented as means ± SE. Statistical data analysis was performed using SigmaStat (Systat Software, USA). Comparisons between the groups were tested using ANOVA on ranks followed by a pairwise multiple comparison. Repeated measurements were tested using the Mann-Whitney Rank Sum Test. Statistical significance was accepted at p<0.05. BCECF- [min]
